5000th patient treated with protons for eye tumours
From the patient's perspective at the treatment station: The proton beam is directed through the hole in the shield onto the tumour in the eye. The brass shield is adjusted to the individual tumour size and protects the surrounding tissue. © HZB/. S. Kodalle
The treatment centre for eye tumour therapy in Berlin-Wannsee © HZB/ S. Kodalle
For more than 25 years, Charité – Universitätsmedizin Berlin and the Helmholtz-Zentrum Berlin (HZB) have been jointly offering proton radiation therapy for eye tumours. The HZB operates a proton accelerator in Berlin-Wannsee for this purpose, while Charité provides medical care for the patients. The 5000th patient was treated at the beginning of August.
The treatment room and proton accelerator are specially adapted to the requirements for optimal and highly precise treatment of tumours inside the eye and are unique in this combination. The largest group of tumours in the eye is the rare and malignant uveal melanoma, which, as the name suggests, develops in the uvea of the eye.
Proton therapy is used as an effective method of fighting tumours, often as an alternative to removing the eye, with the aim of preserving the eye and its function as much as possible. The protons can be directed very precisely at the tumour, sparing the surrounding healthy tissue. Compared to other radiation methods, proton therapy causes less damage to the cornea, lens, retina and optic nerve in many cases.
8 August 2025 was a special day: it was the day on which the 5000th patient completed their eye tumour treatment. This makes the Berlin experts one of the world's leading centres: together, the two institutions (Charité and HZB) have treated 10 percent of all eye tumours treated with protons worldwide. The cooperation with Charité – Universitätsmedizin Berlin also opens up prospects for the further development of proton therapy in order to carry out even more precise and effective treatments in the future – for the benefit of patients.
- Sasol and HZB deepen collaboration with strategic focus on digitalisationSasol Research & Technology and Helmholtz Zentrum Berlin (HZB) are expanding their partnership into the realm of digitalisation, building on their joint efforts in the CARE-O-SENE project and an Industrial Fellowship launched earlier this year. This new initiative marks a significant step forward in leveraging digital technologies to accelerate catalyst innovation and deepen scientific collaboration.
- Technology Transfer Prize Ceremony 2025This year’s Technology Transfer Prize Ceremony will take place on October 13 at 2 pm in the Lecture Hall, BESSY II Building, Adlershof.
- Novel technique shines light on next-gen nanomaterials: how MXenes truly workResearchers have for the first time measured the true properties of individual MXene flakes — an exciting new nanomaterial with potential for better batteries, flexible electronics, and clean energy devices. By using a novel light-based technique called spectroscopic micro-ellipsometry, they discovered how MXenes behave at the single-flake level, revealing changes in conductivity and optical response that were previously hidden when studying only stacked layers. This breakthrough provides the fundamental knowledge and tools needed to design smarter, more efficient technologies powered by MXenes.